| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 77.3924 | 71 |
| GSM780708 | Untreated after 4 days (C2_1) | 78.12 | 71 |
| GSM780709 | Untreated after 4 days (C3_1) | 63.836 | 67 |
| GSM780719 | Untreated after 4 days (C1_2) | 74.1142 | 70 |
| GSM780720 | Untreated after 4 days (C2_2) | 82.8122 | 72 |
| GSM780721 | Untreated after 4 days (C3_2) | 70.0483 | 69 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 72.0687 | 70 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 56.2285 | 61 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 81.2958 | 72 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 74.3691 | 70 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 74.6058 | 70 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 85.5433 | 73 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 65.0769 | 67 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 70.8918 | 69 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 72.2994 | 70 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 62.8648 | 66 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 69.3594 | 69 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 77.3113 | 71 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 59.1164 | 64 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 59.6151 | 64 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 59.7819 | 64 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 55.9427 | 61 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 60.746 | 65 |